SIGNIFY the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in pati

SIGNIFY the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in pati

SIGNIFY the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in pati

(Clics: 101;Site ajouté: May 8, 2015)

Description:

The SIGNIFY trial is testing the hypothesis that treatment with ivabradine reduces mortality and cardiovascular events in patients with stable coronary artery disease (CAD), without clinical heart failure.